Data / Form D filings / Nortis Inc
Nortis Inc: Form D filings
Nortis Inc, a biotechnology company in Woodinville, WA, filed 15 Form D notices with the SEC between 2009 and 2022. The latest, on August 10, 2022, reports $6 million sold of a $9.5 million offering to 3 investors.
Find out what Nortis Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 17280 WOODINVILLE-REDMOND ROAD NE, SUITE B-828, Woodinville, WA, 98072
- Phone
- (206) 245-4193
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1416214
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2022 | New notice | $9,500,000 | $6,000,000 | $3,500,000 | 3 | Aug 8, 2022 | sec.gov |
| Jan 10, 2022 | New notice | $3,000,000 | $1,500,000 | $1,500,000 | 2 | Jan 7, 2022 | sec.gov |
| Jun 15, 2021 | New notice | $1,000,000 | $1,000,000 | $0 | 3 | Jun 4, 2021 | sec.gov |
| Jun 15, 2021 | New notice | $1,500,000 | $1,500,000 | $0 | 3 | Jun 4, 2021 | sec.gov |
| Jul 18, 2017 | Amendment | $500,000 | $323,200 | $176,800 | 10 | Aug 3, 2016 | sec.gov |
| Jun 30, 2017 | Amendment | $5,000,000 | $12,500 | $4,987,500 | 1 | Aug 1, 2016 | sec.gov |
| Aug 5, 2016 | New notice | $500,000 | $0 | $500,000 | 0 | Yet to occur | sec.gov |
| Jun 30, 2016 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Mar 19, 2015 | New notice | $3,399,999 | $408,845 | $2,991,154 | 1 | Mar 5, 2015 | sec.gov |
| Jul 7, 2014 | New notice | $2,000,000 | $1,000,000 | $1,000,000 | 1 | Jun 27, 2014 | sec.gov |
| Mar 26, 2014 | Amendment | $1,500,000 | $1,242,250 | $257,750 | 22 | Mar 16, 2012 | sec.gov |
| Mar 27, 2013 | Amendment | $1,000,000 | $427,500 | $572,500 | 9 | Mar 16, 2012 | sec.gov |
| Mar 28, 2012 | New notice | $1,000,000 | $10,000 | $990,000 | 2 | Mar 16, 2012 | sec.gov |
| Nov 18, 2011 | New notice | $15,000 | $15,000 | $0 | 1 | Nov 9, 2011 | sec.gov |
| Oct 27, 2009 | New notice | $60,000 | $13,000 | $47,000 | 2 | Aug 20, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Makoto Shintani | Director | |
| Greg Corona | Director | |
| Susan Preston | Director | |
| Thomas Neumann | Executive Officer, Director | |
| Paul Conley | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Aug 8, 2022 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Nortis Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.